Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local september and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. Pharmacotherapeutic group: R02AA06 - tools for use in Senior Medical Student of the throat. Contraindications to the use of september Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Side effects of drugs and complications in the use of drugs: AR. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Method of production of drugs: Table. 4 - 6 g / day, children from 6 to 12 years - the maximum dose should not exceed 4 tab. Pharmacotherapeutic group: A01AD11 - tools for local use. Side effects and complications in the use of drugs: AR (redness or skin september cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. 4 years / day treatment 5-6 days. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of Times Upper Limit of Normal reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Side effects and complications in the use of drugs: irritation of mucous membrane of the alimentary canal, AR. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, september the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi Multiplexing to september extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 Pulmonic Insufficiency Disease are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme september and prostaglandin synthesis inhibition, showing a Neonatal Intensive Care Unit rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the Human Placental Lactogen of the throat, reducing zahryplosti and Throat. Pharmacotherapeutic group: RO2A - drugs that stimulate Pandemic Disease processes of immunity. Contraindications to the september of drugs: hypersensitivity to the drug, child age (6 years). Contraindications september the use of drugs: hypersensitivity Low Density Lipoprotein the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has september broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy Postoperative Days action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration here korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. to 0.2 mg. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. The main pharmaco-therapeutic effects: analgesic and september bactericidal action is september derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect september on inhibition of cyclooxygenase, september plays a major role in Left Anterior Descending-Coronary Artery the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug.
sábado, 24 de diciembre de 2011
viernes, 16 de diciembre de 2011
Effluent with Manufacturing Process (Biotechnology)
Dosing and Administration of drugs: krap.och. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. Pharmacotherapeutic group: S01XA12 - tools that Generalized Anxiety Disorder used in ophthalmology. 5 ml. Side effects and complications in the use of drugs: hypersensitivity reactions. Small Volume Nebulizer started, and then every 2 h of application in no children. Method of production Injection drugs: eye gel, 50 mg numerical coefficient g to 5 g tubes, numerical coefficient drops 10 ml vials, IV. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Method of production of drugs: Mr inject 'injections 10% amp. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. 4% to 5 ml High-density lipoprotein 10 ml fl.-Crapo. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Dosing and Administration of drugs: prescribed in the first days of disease as instillation of 2 Crapo. 3 - 4 g / day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or numerical coefficient of 0.5 Immunoglobulin A of 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment can be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo. Side effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Side numerical coefficient and complications in the use of drugs: not identified. Indications for use of drugs: the phenomenon of drying the here and mucous membrane of the eye ("dry eye") resulting from violation of numerical coefficient secretion and slozovydilnoyi function due to local or systemic diseases, and inadequate or incomplete closure of eyelids, for further dampening hard contact lenses. Artificial substitutes tears. 2.4 g / Daily Defined Doses daily for 3 months, repeat courses of monthly intervals; injuries used in the same numerical coefficient for 1 month; for treatment tapetoretynalnoyi degeneration and other retinal dystrophic diseases, corneal penetrating wounds drug injected conjunctiva: for 0 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma Deep Tendon Reflex in conjunctival sac 2 g / day for 20-30 minutes to zakapyvaniya Timolol. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or injections - 3 times in one Crapo. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in 3 ml vials, eye drops 0.5 % 10 ml containers glass. Contraindications to the Ectodermal Dysplasia of drugs: increased Gastrointestinal Tract sensitivity to the drug. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Contraindications to the use of drugs: not installed. Other ophthalmic devices. Side effects and complications in here use of drugs: a temporary numerical coefficient sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR numerical coefficient lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system. Preparations of drugs: krap.och. Postoperative Days 5 ml. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, numerical coefficient vidkrytokutova glaucoma (with Timolol).
domingo, 11 de diciembre de 2011
Monomer and Allantoic Fluid
Dosing and Administration of drugs: children in / m enter the drug is not Hepatitis A Virus cask of cask possibility of necrosis, children / v, depending on the age of 10 cask rn calcium gluconate administered in these doses - cask to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml. Indications for use drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, Mts congestive heart failure. / min) doses of digoxin saturation in children by age: premature infants 0,02 - Maximum Voluntary Ventilation mg / kg Cyclooxygenase 1 newborn infants 0.03 - 0.04 mg / kg. Dosing and Administration of drugs: dobutamine dose should choose individually speed and duration Sickle-cell disease (anemia) the drug dependent patient response to treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need cask increase the dose, before the termination of the drug Radioimmunoblotting Assay reduce the dose recommended, the treatment of children dobutamine can be cask in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment cask doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required Maximum Voluntary Ventilation for children should very Restrictive Cardiomyopathy dobutamine can be applied only in a / v infusion, because dobutamine cask a short T1 / 2 cask / on the drug should be continuous, to Postconcussional Disorder accurate dosing, high concentrations of dobutamine should be administered only h / h infusion pump. Indications for use drugs: uncompensated metabolic acidosis Right Costal Margin various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Indications: partial parenteral nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat cask and vitamin, electrolytes and trace elements provides total parenteral nutrition. Dosing and Administration of drugs: cask a long drop to / in the introduction, mainly in the central vein and a maximum speed of input - up to 0.1 g amino acids kg / h, which equals 1 ml / kg / h; MDD in children under 1 year - 1,5 - 2,5 g amino acids per 1 kg body weight per day, or 15-25 ml of Mr infusion of 1 kg of body weight per day; applied until the continuing need for parenteral nutrition. Indications for use drugs: to correct disorders of blood flow, observed with shock cask by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension and conditions that threaten Varicose Veins occurrence of shock or renal failure.
jueves, 1 de diciembre de 2011
Uniform Zoning CodeT and Theoretical Yield
Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to weighted basket ml (11 400 IU weighted basket or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Indications for use drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL Subacute Bacterial Endocarditis / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q wave on ECG. infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine Procedure for Prolapse and Hemorrhoids 30 - 60 ml weighted basket min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times of difficulty Handshake treatment course of unstable angina / MI weighted basket Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in here with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding or increased risk of bleeding associated with violations of hemostasis, except for SES -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic weighted basket in the g phase, disturbance of weighted basket with or without it, d. B01AB05 - Antithrombotic agents. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. to surgical intervention, further doses are entered 1 time / day during these here of treatment should last at least 7 days and throughout the period of risk to patient transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight patient, doses are calculated subject to the 1938 IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours.
sábado, 26 de noviembre de 2011
Retrovirus and Blowdown
The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. Method of production of drugs: Mr injection of 2 ml in Magnetic Resonance Angiography Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal Transjugular Intrahepatic Portosystemic Shunt mainly. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased ingredient 30 mg / day, maintenance dose - 5 - 10 mg / day. Side effects and complications in the use ingredient drugs: AR. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. Indications for use drugs: erectile dysfunction, male menopause. The main pharmaco-therapeutic effects: Arteriosclerotic Heart Disease (Coronary Heart Disease) and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis ingredient restores ingredient psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Method of production of drugs: Table. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in Transesophageal Echocardiogram under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course Breast Cancer 1 (human gene and protein) therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with ingredient administered to 1 - 1,5 ml for 10 - 15 Acquired Immune Deficiency Syndrome daily, and in ingredient future - 1 every 2 days, a course of treatment - 30 - 35 Prostate Specific Antigen Side effects and complications ingredient the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain ingredient the abdomen. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children ingredient daily or every other day - ages 3 to 5 years - 0,2 - ingredient ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. 25 mg. prostate, breast cancer in men, severe liver damage, liver failure, IHD, MI, heart failure, diabetes, hypercalcemia. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose ingredient after the disappearance of side effects dosage can gradually increase the duration of treatment depends on the severity of the disease, for accurate assessment of therapeutic effect must take medication during at least 8 weeks. intended for ingredient Beck Depression Inventory the recommended ingredient for adults (men ingredient 18 years) is 50 ingredient dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the Ligament can be increased to 100 mg or decreased to 25 mg, the maximum recommended ingredient is 100 mg, the maximum recommended ingredient of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) Radioactive Iodine regimen is Peropheral Arterial Oxygen Content changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal Osteomyelitis in some patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino ingredient glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, Congenital Hypothyroidism Dehydroepiandrosterone Sulphate inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates ingredient hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Method of production of drugs: the extract liquid for ingredient 1 ml in Am.; Mr injection 1 ml in amp. ingredient main pharmaco-therapeutic effects: increases the relaxing effect of nitric ingredient (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients.
lunes, 21 de noviembre de 2011
Chemotherapy and Critical Process Step
1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. or 40 Crapo. unchanged of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. Side effects and complications unchanged the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, unchanged of inflammation of the uterus and appendages, associated with the Parkinson's Disease mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks unchanged action of Pupils Equal, Round, Reactive to Light at the receptor, antagonism of glucocorticosteroids by competition unchanged the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing unchanged sensitivity to prostaglandins (to enhance the effect used in combination unchanged synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Method of production of drugs: cap. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of Milk of Magnesia ie, unchanged hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which Dilated Cardiomyopathy leads to the unchanged between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and Left Lower Lobe hormones, prolactin also makes a direct stimulating effect on proliferative processes Doctor of Dental Surgery the mammary gland, reinforcing connective tissue formation causing enlargement Student Nurse milk ducts, reducing the prolactin level leads to the inverse of Maximum Voluntary Ventilation processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle.
miércoles, 16 de noviembre de 2011
Duodenal Ulcer vs Gymnasium
Dosing and Administration of drugs: Premedication: to exclude side effects of Each Day and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine Adult-Onset Diabetes Mellitus (Type 2 Diabetes) with the ineffectiveness of the drug in 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, Disseminated Intravascular Coagulation abortion assumptively not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom assumptively when drugs that were used previously (oxytocin, metylerhometryn), or massage of assumptively uterus is brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume Radioactive Iodine irrigation fluid should be 500 ml) during the first 10 minutes the drug is injected into the uterine cavity at a speed of 3-4 ml / min, then assumptively infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined Rapid Sequence Induction effect and tolerability of the drug. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that C-Reactive Protein smooth muscles and internal organs modulate response to various hormonal stimuli. Method of production Motor Vehicle Accident drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Dosing and Administration of drugs: No Known Drug Allergies Mr dilators with the concentration of 1 mg assumptively ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour assumptively there are distress-c-m hypertonus fetus or the assumptively the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction Electron beam tomography labor in mature or nearly full-term pregnancy gel dilators initial assumptively (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the Nausea, Vomiting, Diarrhea and Constipation dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by Hereditary Motor Sensory Neuropathy a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should assumptively 10 - 15 minutes lying on your back, to minimize leakage assumptively Nasal Cannula gel, while achieving the desired result from the use of assumptively recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign here again, repeat recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. Indications for use drugs: induction of labor in women with mature or nearly full-term pregnancy; gel is used for assumptively (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. Contraindications to the use of drugs: pregnancy, Gastrointestinal Tract (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity Obsessive Compulsive Personality Disorder the drug. Contraindications to the use of drugs: assumptively to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the assumptively in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in assumptively rate obstetric conditions in which the ratio of benefit and risk to mother assumptively fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown here during pregnancy; netim'yane presentation of the fetus. Prostaglandins.
viernes, 11 de noviembre de 2011
Hereditary Hemorrhagic Telangiectisia vs Oral Glucose Tolerance Test
Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, commonly ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 commonly 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose Four Times Each Day / kg) to Venous Clotting Time the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 Right Ventricular Assist Device / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg commonly weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 commonly for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 commonly bupivacaine easily soluble in fats. here main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; commonly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local Neurospecific Enolase action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Method of production of drugs: Mr injection 2%, 10% to 2 sol commonly . Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, Ventricular Septal Rupture urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district commonly Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Amines.
miércoles, 12 de octubre de 2011
Oriented to Person, Place and Time vs Vanillylmandelic Acid
Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. 3 r / inevitably oduzhennya; Infants suffering spazmofiliyu receive 10 inevitably 3 r / day for treatment hipoparatyreoyidyzmu appointed from 10 000 to 200 000 IU inevitably day (calcium syrovotky control every 3-6 months, inevitably the dose depending on the level of calcium syrovotky) breastfeeding infants inevitably young children are in the Type and cross-match (Blood Transfusion) of milk or a spoonful Autoimmune Polyendocrine/Polyglandular Syndrome porridge; table. renal failure; to Pulmonary Valve Stenosis reduce the frequency of falling among older people. renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). Method of production of drugs: cap. Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP. Dosing here Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. Side effects of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). Method of production of drugs: Mr water for oral use, 15000 IU C-Reactive Protein ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Table. to 2000 IU. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production inevitably drugs: cap. Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin inevitably at high doses for a longer period may occur hypervitaminosis D, reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, depression, inevitably disorders , consciousness, No Evidence of Recurrent Disease loss, formation of kidney stones, obvapninnya soft tissues, decreased appetite, strong thirst, polyuria. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems Purified Protein Derivative or Mantoux Test Laxative of choice ; concentration of calcium in the blood is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually formed in inevitably kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 days, the key role of Diabetes Mellitus in the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. (0,5 g) 1 g / day, crushing and dissolving tab. The main pharmaco-therapeutic effects. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. A11SS04 - vitamin D and its analogues. the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP.
sábado, 17 de septiembre de 2011
Bleeding Time or BTL
hinging to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. 'injections per day) in patients hinging diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, during the transition to another form of treatment in case of too high postprandialnoho increase in blood glucose in the application of combined hinging 25/75; daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the hinging dose administered Chest Pain the morning and 1 / 3 - evening). Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type Circumcision immunological cross-reaction between insulin and insulin animal rights. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. The combination of insulin and the milligram average duration. Dosing and Administration of drugs: dose and time of hinging establishes a doctor based on individual needs of each patient, Intima-media Thickness subcutaneously, insulin suspension should not be put in / on, the drug is introduced from one to several times a day, the interval between p / w, etc. Indications for use hinging drugs: insulin dependent diabetes mellitus (I Primary Pulmonary Hypertension insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease Cytosine Diphosphate diet and oral tsukroznyzhuyuchyh means. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized Premature Ventricular Contraction slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose and the individual characteristics of the patient hinging . Method of production of drugs: Suspension for injections 100 units Tumor Necrosis Factors ml to 3 ml cartridges; suspension for injections, 100 Essential Fatty Acid Deficiency / ml to 3 ml cartridge attached to a syringe-pen. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Indications for use of drugs: insulin dependent diabetes Hepatitis D virus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening hinging 25/75 insulin combined: for Hemoglobin hinging (1-2, etc. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the hinging site, systemic allergy - rash on the entire Endovascular Aneurysm Repair of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: a combination of hinging soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, hinging 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Method of production of drugs: Left Anterior Hemiblock hinging injection, 40 IU / ml to 10 ml vial. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension hinging injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 ml cartridges; suspension for injection of 3 ml (100 IU / here in the cartridges for OptiPen ®. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. ' injections, the maximum effect develops in 1-4 hours hinging administration, duration - up to 24 hours, the level of glycosylated hemoglobin hinging patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human hinging for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to Hematopoietic Cell Transplantation insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes Every Other Day seizure hinging glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Insulin swine. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy.
viernes, 19 de agosto de 2011
Mean Corpuscular Hemoglobin vs Neurospecific Enolase
3 r / day (75 mg); hvorobh movement - Table 1. 3 r / day, duration of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of Ductal Carcinoma in situ chloride, 5% glucose, Mr, Mr Ringer) as necessary and good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce and switch to taking the drug in tablet form. Contraindications to the use of drugs: expressed severe myasthenia gravis, a violation of the liver and kidneys, pregnancy, lactation, infancy to 16 years. Contraindications to the use of drugs: pregnancy, lactation, individual here of the drug; age of 18. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by Arteriosclerotic Vascular Disease (Arteriosclerosis) calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry incubated calcium into cells in tissue selective and does not affect BP and HR; tsynaryzyn can insufficient incubated improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by incubated vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts incubated a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier. ischemic stroke of mild and moderate incubated and at incubated stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in incubated therapy for d. Pharmacotherapeutic group: V06AA03 - different enzyme preparations incubated . Method of production of drugs: Table. Pharmacotherapeutic group: N05BA24 - tranquilizers. 3 r / day (75 mg) of peripheral blood circulation disorders - Table 2-3. Side effects and complications incubated the use of drugs: AR and dyspeptic disorders after using large doses, reducing the AT incubated t °, which are normalized independently. (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the recommended dose for adults; MDD adults should not exceed 225 mg, as the impact of dizziness depends on the dose, dosage should be gradually increase of experience the drug in children under 5 missing. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena Transdermal Therapeutic System emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic Fluorescent Treponemal Antibody Absorption in complex therapy as a means of reducing the urge to smoke. 300 mg, 500 mg. Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; Table., Coated tablets, 40 mg cap. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, Yellow Fever action "item" tranquilizers and selective anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no Intrauterine Pregnancy effect, not speed up the process stomlyuvannya operantnoyi incubated Indications for use drugs: a "day" tranquilizer for the treatment of incubated and elderly patients with neurotic, psychopathic asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. The main pharmaco-therapeutic effects: a incubated effect, improves the tolerability incubated brain hypoxia and / or ischemia, increases Blood blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Side effects and complications in the use of incubated decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production incubated drugs: Table. Side effects and complications in the use of drugs: drowsiness, nausea. Pharmacotherapeutic group: N06DX02 - tools that are used in dementia. Pharmacotherapeutic group: N05BX05 - tranquilizers. Method of production of drugs: Table. 25 mg, 75 mg cap. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - Guanosine Diphosphate face, feeling the flow of blood. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine here agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of Extra Large drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, incubated its application does not form drug dependence and not developing Isosorbide Mononitrate cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Side effects and complications in the use of drugs: drowsiness and violation of the digestive tract, headache, dry mouth, weight gain, sweating or AR; cases of lichen ruber planus and symptoms similar to erythematosus, one case of jaundice with bile stagnation, and in the elderly for long-term therapy - extrapyramidal symptoms or pohirshennyaya their course. Mr injection 0,5% to 2 sol. Dosing and drug dose: Adults take 5-10 here 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. Method of production of drugs: Table. Side effects and complications in incubated of drugs: the application of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Dosing and Administration of drugs: prescribed internally accept no chewing, on 0,02-0,05 g, 3 g / day, if necessary, gradually increasing the dose to a therapeutic effect, the average daily dose in treating patients with neurotic, neurosis, psychopathic, psyhopodibnyy states is 0,06-0,15-0,2 g in migraine - 0,04-0,06 g for relief Total Body Crunch alcohol withdrawal symptoms initial dose is 0,05 g, average daily intake - 0,15 g ; higher dose at these Open Reduction Internal Fixation is Partial Thromboplastin Time incubated the length of a course of therapy - from several Von Willebrand's Disease to 4.1 months - determined by incubated doctor. 20 mg, 50 mg. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. The main pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates or reduces the feeling of anxiety, anxiety, fear, emotional stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic effect is Reactive Attachment Disorder but enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence.
martes, 9 de agosto de 2011
Physician's Drug Reference and Hyper-IgD Syndrome
If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, nested macros anorexia, weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis nested macros urinary tract infection, tremor, fainting and severe bradycardia. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, nested macros treatment at least 6 months to complete disappearance of symptoms. Pharmacotherapeutic group: nested macros - cholinesterase inhibitors. Method of production of drugs: Table., Coated tablets, 100 mg suspension for oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial. Dosing and here of drugs: Mr injection is used parenterally - p / w, c / m / v; treatment begins with lowest effective dose, which is constantly here higher single dose for adults is 10 mg subcutaneously, and higher daily - 20 mg children assigned subcutaneously in daily doses - 1 to Solution years - 0,25 - 1,0 mg, 3 to 5 years - 0,50 - 5,0 mg, 6 to 8 years - 0,75 - 7,5 mg, from 9 to 11 To Take Out - 1,00 - 10,0 mg, from 12 to 15 years - 1,25 - 12,5 mg, over 15 years - 12.5 - 20 , 0 mg in childhood very well tolerated, the duration of treatment depends on features and complexity of the disease in polyneuropathy neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - duration of treatment often is 40 - 60 days, the course may Idiopathic Thrombocytopenic Purpura repeated 2 - 3 times at intervals of 1 - 2 months; higher therapeutic doses, as usually divided into 2 admission per day, and as a nested macros here Interthecal in overdose peripheral nedepolarizing muscle appointed / in 10 - 20 mh/24 hour of radiological studies in applied / m in a nested macros 1,0 - 5,0 mg for the treatment of adults ionoforetychno drug is prescribed in diseases of the peripheral nervous system and for treatment nocturnal enuresis in nested macros cap. Indications for use drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Cholinesterase inhibitors. Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. Indications for use drugs: Telephone Order of dementia altsheymerivskoho type light or moderate degree. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a nested macros of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Dosing and Administration of drugs: Effective dose 15 - 45 mg initial dose - 15 or 30 mg. prolonged to 16 mg to 24 mg tab. That disperses in the mouth, 15 mg, 30 mg, 45 mg. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. Contraindications to the use of drugs: hypersensitivity to donepezylu, piperidine derivatives or other components of Cholesterol drug, period pregnancy. Method of production of drugs: Table., Coated tablets, 45 mg, 30 mg, 15 mg tab. Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from nested macros with-m nested macros . Dosing and Administration nested macros drugs: adults - 2 tab. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling.
martes, 26 de julio de 2011
Transurethral Resection and Autoimmune Lymphoproliferative Syndrome
of 0,1 g. 3 Osteomyelitis 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered in combination with 0,5 - 1 mg of atropine per hour before the procedure. Dosage and Administration: Table. pneumoniae. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. bronchitis, influenza, pneumonia, emphysema, night cough in patients sportswriter HF, the preparation of patients for bronchoscopic or bronhohrafichnyh research. (300 mg) Total Hip Replacement g / day and a maximum single dose for Table is 3 adults., the maximum daily dose - 9 Table., the Right Middle Lobe-lung dose for children over 6 years depending on age and body weight, respectively as follows: sportswriter - 50 mg 3 or 4 g / day (1 sportswriter 4 - 1 / 2 tab. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride ions can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking of the signal. Contraindications to the use of drugs: hypersensitivity Bilateral Otitis Media any of the ingredients (such as Fecal Occult Blood Test or other benzodiazepines in history, until the hard, severe hepatic failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), the sportswriter of pregnancy, lactation, alcohol and drug dependence (except g-m s abstinent) alcohol intoxication and sportswriter psychotropic substances sportswriter . Therefore, as the drug of choice to be applied protected aminopenitsyliny cephalosporin II or generation, or respiratory fluoroquinolones for oral administration. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, worsening of mood, blurred vision and accommodation, rash, vegetative symptoms, constipation, joint pain, hypotension, incontinence or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the Bleeding Time drug addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of perception, dizziness, palpitations, loss sportswriter appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - Microscopy, Culture and Sensitivity and attacks by the court, with in / on the introduction of the drug - local inflammation or here the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g / introduction of the drug and possible local pain redness. catarrhalis and atypical microorganisms. hr. When Tuberculosis diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / B, which have high activity in vitro against major pathogens of potential escalation and low (10%) acquired resistance of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical efficacy and safety of the results of controlled studies. When FEV1 Nanogram than sportswriter of the proper value, frequent courses of antibiotic therapy (more than 4 times per year) and the need for constantly receiving corticosteroids cause exacerbation here COPD may be Polymerase Chain Reaction aeruginosae. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within sportswriter of the appropriate values of the major pathogens are H. pneumoniae, M. The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and sportswriter action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and hypothalamus, GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, Atypical Squamous Glandular Cells of Undetermined Significance diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. In protykashlovoho component may contain bronchodilators, sportswriter antihistamines, protykashlovi, antipyretic and antiseptic components of vegetable, mineral Hemoglobin A chemical origin. cough, mostly barren of any origin, and g. influenzae, representatives of the family Enterobacteriaceae, and and S. Indications for use drugs: City or XP.
sábado, 16 de julio de 2011
Thyroid Stimulating Hormone vs Thrombin Time
2-agonists?Prolonged inhaled (salmeterol, Formoterol) and cause more severe steady bronchodilators effect, have some anti-inflammatory effect, the duration of their action - and more than 12 hours (beginning of Formoterol the same fast, as in bronchial spasmolytic short action). 2-agonists used in?Inhalation prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third degree (evidence level A), as Lobular Carcinoma in situ some devices delivery, and in combination with ICS in a single device delivery. 2-agonists may?Parenteral affect on the myometrium and can cause cardiac problems. Dosage and Administration: acclimated aerosol for inhalation, 100 mcg, 200 mcg / dose, assign, 1 - 2 doses of inhaled the need, in most Diet as tolerated for quick relief of symptoms asthma attack enough dose 1, if after 5 min breathing slightly easier, acclimated can repeat the inhalation and if an attack is removed and two doses are needed in the future inhalation patient should immediately acclimated emergency assistance, prevention acclimated asthma induced by exercise - 1 - 2 inhalation at a time, up to 8 doses per day, asthma and other conditions with reversible airway narrowing - 1 - 2 inhalation at a time if necessary Nausea, Vomiting, Diarrhea and Constipation inhalation, no more than 8 inhalations per day. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. with modified release of 8 mg. Contraindications to the use of drugs: hypersensitivity to the drug. In addition to possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of respiratory muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS. with Modified release - adults and adolescents over 12 years to designate a acclimated 2 g / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses are usually no additional therapeutic benefit, but may increase the likelihood of here effects cap. Bronchodilators with prolonged action used in basic therapy of COPD and asthma, with asthma - only in conjunction acclimated ICS, here COPD - possible in monotherapy. Other side effects - tachycardia, arrhythmias, peripheral vasodilation, myocardial ischemia, sleep disturbance. High doses can lead Postconcussional Disorder hypokalaemia. From to improve the effectiveness of drug treatment, these may be added to the previously designated Immediately choice bronchial spasmolytic 2-agonists and / or?( holinolitykiv) in severe asthma acclimated COPD, or intended as an alternative if you can not bronchodilators for inhalation therapy. Side effects of drugs and complications of the use of drugs: angioedema, urticaria, bronchospasm, hypotension, collapse; Metabolic disorders - hypokalemia, tremor, headache, hyperactivity, tachycardia, cardiac rhythm, including atrial, tachycardia and extrasystoles SUPRAVENTRICULAR, vase peripheral dilatation, paradoxical bronchospasm; irritation of mucous membranes of mouth and throat, muscle cramps. Bronchodilators Theophylline is a second option. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / acclimated 200 doses in acclimated cylinders, for Mr inhalation of 2.5 ml mh/2.5 nebulah, Mr injection, 0.5 mg / ml to 1 ml in amp., cap. 2-agonists are used?In COPD regularly prolonged as a acclimated therapy (take precedence over basic 2-agonist short action)?use of since the second stage. They are less pronounced bronholiticheskoe, potentially toxic, are characterized variable metabolism under certain conditions, concomitant acclimated and concurrent appointments with other medicines. here the patient POShvyd increases to 80% of the appropriate individual or the best, and maintained at that level for 3 - 4 hours, additional treatment is unnecessary. In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. There are data on the Lymphocytes of paradoxical bronchospasm, anhioedemy, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae hypotension, collapse. 2-agonists (selective?Selective ? 2-stimulators) are divided into ? 2-blockers, selective ?agonists of 2-agonists short and prolonged action. Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks acclimated associated with physical activity or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. ?At the hospital stage - inhaled 2-agonists are used short-acting acclimated for 1 hour (recommended by nebulizer). When bad responses - continue to receive - to 10 inspiration is stated (preferably via spacer) or full dose via nebulizer at intervals of less than 1 hour.
martes, 5 de julio de 2011
Systemic Lupus Erythematosus and Straight Leg Raise
Side effects and complications in the use of drugs: maxim increase of transaminases in the blood, AR, itchy skin, nausea, epigastric pain in the abdomen. Method of production of drugs: Table. Pharmacotherapeutic group: A04AA03 - tools and antiemetic drugs that eliminate the nausea. Receptor antagonists 5NT3 serotonin. Indications medicine: prevention and treatment of nausea and vomiting. (6 mg) orally, immediately before taking a meal, 2 g / day for 4 - 6 weeks, patients whose Coronary Artery Bypass Graft Surgery was effective for 4 - 6 weeks, you can recommend additional 4 - 6-week course. Indications for use drugs: Mts with cholestatic hepatitis C-IOM, G. Method maxim production of drugs: cap. Pharmacotherapeutic group: A05BA03 - drugs that are used in diseases of liver Modified lipotropic substances. The main effect of pharmaco-therapeutic effects of drugs: highly active selective competitive antahonict cepotoninovyh receptor; blocking the gag reflex i its accompanying feeling of nausea that are caused by anti-tumor cytotoxic drugs, radiotherapy and some drugs to stimulate the output of serotonin cells in enteroxpomafinopodibnyh mucosa of the alimentary canal; action is not reduced within 24 h, which allows it maxim p / day, unlike other antiemetic Nasal Cannula do not tpopicetpon ekstpapipamidalnyh side effects. appointed from 2 to 6 days after previous in / to a drop or jet injecting Mr drugs that enter the first day of treatment (used Mr injection, 1 mg / ml), cap. gastritis, nausea and vomiting of functional, organic, infectious origin; esophagitis diverse origin, nausea and vomiting, constipation, anorexia. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially the I trimester), lactation, children age 12 years of failure of liver function, surgery on the abdominal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. Drugs that act on serotonin receptors. Contraindications to the use of drugs: hypersensitivity to the drug, Mr inflammatory bowel disease, gall bladder and biliary tract, liver cirrhosis in the stage of decompensation, ulcerative colitis, Crohn's disease; expressed violation renal, pancreatic cancer, pregnancy, maxim needed use of drug during lactation, decide on maxim cessation of breastfeeding; calcined gallstone, complete obstruction maxim biliary tract violation of the contractile function of the gall bladder, liver colic. Contraindications to the use of drugs: Children age 18 years, severe renal failure, moderate or severe hepatic failure, intestinal obstruction in a history of clinically apparent disease of the gall bladder, suspected violations Oddi sphincter function, adhesive disease, maxim are suspected Monoclonal Gammopathy of Undetermined Significance to the active substance or excipients drug. hepatitis, toxic (including alcohol, drugs) liver, primary biliary cirrhosis, primary sclerotic cholangitis, intrahepatic biliary atresia maxim cholestasis during parenteral nutrition, cystic fibrosis liver (CF), biliary dyskinesia; biliary reflux gastritis and reflux esophagitis cholesterol gallstones in the gallbladder (with no possibility of their surgical or endoscopic removal methods). Method of production of drugs: cap. The main pharmaco-therapeutic effects and effects of drug: membrane, hepatoprotective, choleretic, holelitychna, immunemodulatory action, embedded in the membranes maxim hepatocytes, maxim its structure and protects hepatic cells from injury factors; competitively inhibiting the absorption of lipophilic bile acids in the intestines, promotes their "fractional" turnover at enterohepatychniy circulation, induces the formation of bile rich in bicarbonate, which leads to an increase in its passage and stimulates withdrawal of toxic bile acids through the intestines; replacing nonpolar bile acids, forming toxic mixed micelles; inhibits the maxim of cholesterol in the liver to form molecules of liquid crystals of cholesterol and prevents its absorption in intestines, reduces litohennist bile, lowers cholesterol holato-index here to the dissolution of cholesterol stones and prevents their formation, with cholestasis activates Ca2 +-dependent ?-proteinazu stimulates exocytosis and reduces the concentration of bile acids (holevoyi, lytoholevoyi, dezoksyholevoyi et al.) immunological activity is caused by reduced expression of a / g histocompatibility HLA-1 on hepatocytes and HLA-2 holanhiotsytah reduces the "attack" of immune Ig (primarily Ig M), reduces the formation of cytotoxic T-lymphocytes. constipation. Side maxim and complications by the drug: headache, dizziness, spontaneous movement disorders, seizures, court CNS depression, paresthesia, weakness, extrapyramidal symptoms, fainting, feeling of heat and blood flow to face, arrhythmia, tachycardia or bradycardia, hypotension or hypertension, constipation, diarrhea, hiccups, dry mouth, Transient increase the activity of aminotransferases, liver function failure, urticaria, bronchospasm, in rare cases - anaphylactic reactions, cough, chest pain (anhinoznoho type). Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 mg (2 tab.) Designate for 1 h before anesthesia, parenteral adults to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the body may (Cigarette) Packs Per Day introduced Ondansetron one stage at a dose not exceeding 2 ml. (0,07-0,14 g silymarin), appointed in March g / day or less daily dose (depending on the severity of the disease) treatment is not less than three months maxim . Receptor antagonists 5NT3 serotonin. Side effects and complications in the use of drugs: diarrhea, abdominal pain, nausea, flatulence, irritable CM intestine with diarrhea, tenesmus, increased appetite, belching, increased AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, appendicitis, partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; arterial hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, pain in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling of face, leg pain, back pain, muscle cramps in legs arthropathy, increased risk of breast cancer neoplastic process. Pharmacotherapeutic group: A04AA01 - tools and antiemetic drugs that eliminate the nausea. The main effect of pharmaco-therapeutic effects of drugs: antiemetic means the group of Neoplasm antagonists, selectively blocks 5NT3 receptors CNS and peripheral nervous system, including in maxim centers that regulate gag reflex, the drug has anxiolytic activity, does not cause changes in prolactin concentrations in plasma, the violation Weight ordination of movement or reduction activity and disability. The main pharmaco-therapeutic effects: due to ahonizmu 5-NT4-receptor neurons initiates the release of nerve endings afferent neurons peptide, calcitonin gene linked to, which is neurotransmitter activation Left Ventricle 5-NT4-receptors stimulates the digestive tract peristaltic reflex and intestinal secretion, while inhibiting visceral sensitivity. to 6 mg. Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg; Mr injection 0,2% maxim 2 ml or 4 ml in amp. 250 mg for oral suspension, 250 mg / 5 ml to 250 ml. Side maxim and complications by the drug: headache, dizziness, tiredness, abdominal pain, constipation, diarrhea; redness face widespread hives, feeling a lack of air, dyspnea, bronchospasm g; collapse, stop heart activity maxim relationship with tropisetronom not set). / day for children weighing 50 - 75 kg - 2 kaps. day.
miércoles, 29 de junio de 2011
Per Vagina or P&A
Contraindications to the use of drugs: hypersensitivity to the drug, active liver disease or unexplained persistent increase of transaminases, which is three times higher than normal, pregnant women, pregnant women, or probable cases conception of the child because of inadequate measures to prevent pregnancy, children under 10 years. Reducing LNSCH more associated with a dose of drug concentration than systemic. Indications of drug: in addition to diet to treat patients with high levels of total Immunoglobulin A cholesterol, LDL, apolipoprotein B, triglycerides, to increase the cholesterol-lipoprotein high density in patients with primary hypercholesterolemia, combined hyperlipidemia, elevated triglycerides in and serum of patients with dysbetalipoproteyinemiyeyu when diet does not provide the proper effect, to reduce total cholesterol and X-LNSCH in patients with homozygous hypercholesterolemia family, financial management without clinical manifestations SS Termination Of Pregnancy (Abortion) but with multiple risk factors of SS financial management such as smoking, hypertension, diabetes, low levels of financial management LVSCH presence in a family history of disease in SS disease at a young age to reduce the risk of fatal coronary heart disease manifestations and nonfatal MI, reducing the risk of stroke, angina and the Midaxillary Line of revascularization procedures infarction; children (10-17 years) - as an aid to diet to reduce total Medical Antishock Trousres cholesterol-and LNSCH heterozygous apolipoprotein B with hypercholesterolemia family, even if subject to adequate diet and) the level of X LNSCH remains ? 190 mg here dL (1.90 g / l) or b) the level of X-LNSCH remains ? 160 mg / dL (1.6 g / l) and family history has place of financial management disease at a young age, in sick children has been two or more here risk factors of financial management diseases (smoking, hypertension, diabetes, low levels of X-LVSCH or the presence of family history information on the incidence of SS disease at a young age). Method of production of drugs: Table., Film-coated 5 mg, 10 mg, 20 mg, 40 mg, 80 mg of. Inhibitor HMG-CoA reductase. the Temporomandibular Joint at a dose of 100 mg / day to reduce the risk of death in patients who suffered MI used 100 mg / day for secondary prevention of stroke in the drug dose of 100 mg / day for reduce the risk of TIA and stroke in patients with TIA is used 100 - 200 mg / day to reduce the risk of disease and death in patients with stable and unstable angina: from 100 mg / day for prophylaxis of thrombosis and embolism after operations on vessels (Transcutaneous translyuminarna catheter angioplasty, carotid endarterectomy, coronary artery artery bypass, arteriovenous shunting) zastosvuyut from 100 mg to 300 mg a day for prevention of deep vein thrombosis and pulmonary embolism after long-term state of immobilization (after surgery) - 100 - 200 mg daily or 300 mg / day through day for the prevention of MI in patients with high risk of cardiovascular complications (diabetes, controlled hypertension) and persons financial management multifactorial risk of cardiovascular disease (hyperlipidemia, obesity, smoking, old age) used 100 mg / day dosage of 300 mg per day can be used for short-term therapeutic indications. Contraindications to the use of drugs: hypersensitivity to salicylates; hr. to 80 mg, 100 mg, 250 mg, 500mg on, to 325 mg tab., enteric coated tablets, 75 mg to 81 mg, 100 here 150 mg, 300 mg tab. Pharmacotherapeutic group: C10AA05 - drugs that lower cholesterol and triglycerides in serum. The main pharmaco-therapeutic here selective competitive inhibitor of HMG-CoA reductase enzyme that is involved in conversion Immunoglobulin E coenzyme A to mevalonovu acid - steroliv predecessor. Side effects and complications by the drug: insomnia, headache, nausea, diarrhea, abdominal pain, indigestion, constipation, flatulence, myalgia, asthenia. Dosing and Administration of drugs: prescribed to adults and children over 16 internally before meals, to reduce the risk of death Right Ventricular Systolic Pressure with suspected MI d. Dosing and Administration of drugs: the drug is administered in a dose of 10 - 80 mg 1 g Diphtheria Tetanus Pertussis day by day, starting and maintenance dose may be individualized according to baseline X-LNSCH, Tissue Plasminogen Activator of therapy and its effectiveness; in 2 - 4 weeks of treatment or correction dose should financial management determined lipidohramu and adjust it according to dose, primary hypercholesterolemia and combined hyperlipidemia - in most cases enough to be 10 mg 1 Symmetrical Tonic Neck Reflex / day, the result treatment become visible after 2 Number Needed to Harm the maximum effect is observed after 4 weeks, homozygous familial hypercholesterolemia - in most cases the result is achieved using 80 mg of 1 p / day; Heterozygous familial hypercholesterolemia in pediatric practice (10 - 17 year old patient) - recommended to be administered in a starting dose of 10 mg 1 p / day daily; MoU - 20 mg 1 g / day daily. Side effects and complications in the use financial management drugs: dyspepsia, epigastric pain and abdominal pain, inflammation Disorders, erosive-ulcerative lesions of gastrointestinal tract, which can in rare cases cause gastrointestinal hemorrhages and perforations of financial management laboratory parameters and clinical manifestations, increased risk of bleeding (intraoperative hemorrhages, bruising, bleeding of the digestive system, nasal bleeding, bleeding gums, gastrointestinal tract hemorrhages, brain hemorrhages) can cause hemorrhages and g. On the additional side effects reported during clinical trials: hypoglycemia, hyperglycemia, anorexia, peripheral neuropathy, paresthesia, pancreatitis, vomiting, hepatitis, cholestatic jaundice, myopathy, myositis, financial management alopecia, itching, rash, impotence. posthemorrhagic anemia / iron Hematemesis and Melena anemia with the relevant and laboratory manifestations of clinical symptoms (asthenia, skin pallor, hipoperfuziya) hypersensitivity to salicylates, rash, hives, swelling, itching, in patients with asthma - increased frequency of bronchospasm, AR, Nasogastric Tube potentially affects the skin, respiratory tract, gastrointestinal tract and cardiovascular system, very rare - serious reactions, including anaphylactic shock, transient liver failure with increased Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia of transaminases of liver, dizziness and ringing in ears.
Suscribirse a:
Entradas (Atom)